RMD

Resmed Stock Analysis

AI Rating

Good
  • Quality9/10
  • Growth 5/10
  • Momentum 5/10
Resmed sales and earnings growth
RMD Growth
Neutral
  • Revenue Y/Y 9.57%
  • EPS Y/Y 19.55%
  • FCF Y/Y 28.73%
Resmed gross and profit margin trends
RMD Profitability
Great
  • Gross margin 60.90%
  • EPS margin 27.50%
  • ROIC 56.30%
Resmed recent dividend growth
RMD Dividends
  • Dividend yield 0.92%
  • Growth 3Y 10.83%
  • Payout ratio 22%
Resmed net debt vs free cash flow
RMD Risk
Great
  • Debt / Equity 0.1
  • Debt / FCF 0.0
  • Interest coverage 93.8

Resmed stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Medical Instruments & Supplies stocks ↗